advertisement

diseases & conditions

rare diseases: 'it can take an average of five years for a diagnosis'

mps i is now on the newborn screening panel in ontario, thanks to advocates like kim angel, executive director of the canadian mps society.
vanessa hrvatin
feb 28 2022

heart failure is on the rise in canada. do you know what to look out for?

the early stages of this common disease are often overlooked by those who have it
fiona roossien, postmedia content works
feb 28 2022

'this disease will slowly rob me of everything': why are canadians living with rare diseases waiting for treatment?

covid has proven we can quickly set up infrastructure without long-term clinical data. it's time to do the same with rare diseases, says durhane wong-rieger, president and ceo of canadian organization for rare disorders.
vanessa hrvatin
feb 28 2022

survey sheds light on how emotional labour has taken a toll on various workers throughout pandemic

research has shown that without proper workplace supports, emotional labour can cause many problems which include burn-out and becoming detached from feelings.
brighter world, mcmaster university
feb 25 2022

ai catches two life-threatening heart conditions that are often missed

patients often go years, sometimes decades, without getting a proper diagnosis for hypertrophic cardiomyopathy and cardiac amyloidosis.
chris arnold
feb 25 2022

canada's lethal 'postal code lottery': why won't ontario and the atlantic provinces fund life-saving take-home cancer drugs?

the cancertainty coalition wants fair and equal access to cancer drugs regardless of where you live.
robin roberts
feb 25 2022

researchers are using worms to figure out how humans can live longer

if we could treat aging as a disease, we'd also be addressing conditions that typically affect older communities like cardiovascular issues and cancer, say experts.
chris arnold
feb 24 2022

health canada authorizes canadian-made covid vaccine

covifenz, a two-dose covid vaccine from quebec city-based medicago, is now authorized for use in people aged 18 to 64.
the canadian press
feb 24 2022
powered by
save your skin foundation
powered by
movember canada

rare diseases: 'it can take an average of five years for a diagnosis'

mps i is now on the newborn screening panel in ontario, thanks to advocates like kim angel, executive director of the canadian mps society.
vanessa hrvatin
feb 28 2022

heart failure is on the rise in canada. do you know what to look out for?

the early stages of this common disease are often overlooked by those who have it
fiona roossien, postmedia content works
feb 28 2022

'this disease will slowly rob me of everything': why are canadians living with rare diseases waiting for treatment?

covid has proven we can quickly set up infrastructure without long-term clinical data. it's time to do the same with rare diseases, says durhane wong-rieger, president and ceo of canadian organization for rare disorders.
vanessa hrvatin
feb 28 2022

survey sheds light on how emotional labour has taken a toll on various workers throughout pandemic

research has shown that without proper workplace supports, emotional labour can cause many problems which include burn-out and becoming detached from feelings.
brighter world, mcmaster university
feb 25 2022

ai catches two life-threatening heart conditions that are often missed

patients often go years, sometimes decades, without getting a proper diagnosis for hypertrophic cardiomyopathy and cardiac amyloidosis.
chris arnold
feb 25 2022

canada's lethal 'postal code lottery': why won't ontario and the atlantic provinces fund life-saving take-home cancer drugs?

the cancertainty coalition wants fair and equal access to cancer drugs regardless of where you live.
robin roberts
feb 25 2022

researchers are using worms to figure out how humans can live longer

if we could treat aging as a disease, we'd also be addressing conditions that typically affect older communities like cardiovascular issues and cancer, say experts.
chris arnold
feb 24 2022

health canada authorizes canadian-made covid vaccine

covifenz, a two-dose covid vaccine from quebec city-based medicago, is now authorized for use in people aged 18 to 64.
the canadian press
feb 24 2022
powered by
save your skin foundation

advertisement

advertisement